ENDRA Life Sciences Announces Issuance of Three New U.S. And European Patents
Portfolio Pulse from Benzinga Newsdesk
ENDRA Life Sciences has been issued three new patents in the U.S. and Europe, strengthening the proprietary position of its TAEUS system. The patents relate to a novel radio frequency applicator, a method and system for monitoring tissue temperature during surgical procedures, and a method and system for determining fractional fat content of tissue. The company's portfolio now includes 67 issued patents globally.
August 23, 2023 | 12:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The issuance of three new patents to ENDRA Life Sciences strengthens the proprietary position of its TAEUS system, potentially increasing the company's competitive advantage and market share.
The issuance of new patents often leads to increased investor confidence as it demonstrates a company's ability to innovate and protect its intellectual property. This can potentially lead to increased market share and competitive advantage, positively impacting the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100